Mourant Ozannes advises on privatisation offer for China Nepstar

Mourant Ozannes acted as Cayman Islands counsel for the buyer group in connection with the take-private of China Nepstar Chain Drugstore Ltd., a Cayman Islands exempted company formerly listed on the New York Stock Exchange. The take-private was effected by way of a Cayman Islands statutory merger, pursuant to which China Nepstar ceased to be a publicly traded company and became a wholly-owned subsidiary of the buyer group.

China Nepstar Chain Drugstore Ltd. is a leading retail drugstore chain in China. As of September 30, 2015, the Company had 1,965 directly operated stores across 71 cities, one headquarter distribution centre and 14 regional distribution centres in China. China Nepstar uses directly operated stores, centralised procurement and a network of distribution centres to provide its customers with high-quality, professional and convenient pharmaceutical products and services and a wide variety of other merchandise, including OTC drugs, nutritional supplements, herbal products, personal care products, family care products and convenience products.

The Mourant Ozannes team was led by partner Simon Lawrenson, assisted by associate Peter Vas.